חוב לטווח קצר להון: AngioDynamics Inc (ANGO)
AngioDynamics, Inc. (ANGO) generates revenue through the sale of vascular therapy systems and oncology equipment. FDA certifications and patent protection ensure a high barrier to entry. The asset value of 0.02 shown on this chart reflects the financial dynamics. A team of top-tier engineers drives innovation here, receiving competitive benefits and long-term job security in return.
פילוחים אנליטיים של חברת AngioDynamics, Inc.
An optimal capital structure separates sustainable development from risky speculation. The strategic focus of AngioDynamics, Inc. (ANGO) on high-tech proprietary devices in vascular surgery strengthens its financial foundation. The dynamics of the short-term debt-to-equity ratio reflect the proportion of current loans to equity, revealing the dependency on short-term borrowings. Low values of this ratio confirm the business's protection against credit shocks and its high solvency.